1. Background {#sec109538}
=============

*Pseudomonas aeruginosa* is an important Gram-negative opportunistic pathogen that has the capability to create variable clinical infections, including, but not limited to, wound infections, urinary tract infections (UTIs), and blood stream infections (BSI), particularly in hospitalized and immunocompromised patients ([@A20130R1], [@A20130R2]). *Pseudomonas aeruginosa* was the second most common cause of hospital-acquired pneumonia, as well as the third and fifth common cause of hospital-acquired UTIs in USA and Europe, respectively ([@A20130R2]-[@A20130R4]). Evidently, *P. aeruginosa* due to low permeability of its outer membrane in combination with efflux pump overexpression is intrinsically resistant to a variety of antibiotics ([@A20130R5]). Expression of different classes of extended-spectrum β-lactamas enzymes along with aminoglycoside-modifying enzymes (aminoglycoside phosphoryltransferases, aminoglycoside acetyltransferases, and aminoglycoside nucleotidyltransferases), and mutation are other well-characterized mechanisms for antibiotic resistance in *P. aeruginosa* ([@A20130R6], [@A20130R7]). Data extracted from several independent studies in Iran showed that *P. aeruginosa* was responsible for 11%-32.4% of UTIs, 17.2%-32.4% of pneumonia, 36.7% of BSI, and 47% of wound infections ([@A20130R8]-[@A20130R12]). Moreover, based on previous studies performed in Iran, treatment of *P. aeruginosa* infections is a major concern for health-care setting due to its high resistant rate to different antibiotics ([@A20130R12], [@A20130R13]).

Since determining bacterial isolates relatedness is essential for understanding the transmission routes, different typing methods that can be divided into two major categories, phenotypic and genotypic methods, have been established ([@A20130R14]). Phenotypic methods such as serotyping, pyocin typing, and antimicrobial susceptibility typing depend on the environmental factors, therefore, have low discriminatory power ([@A20130R14], [@A20130R15]). Genotypic methods have been performed by different typing techniques such as Restriction Fragment Length Polymorphism (RFLP), Pulsed Field Gel Electrophoresis (PFGE), Multilocus Sequence Typing (MLST), Enterobacterial Repetitive Intergenic Consensus-PCR (ERIC-PCR), Variable Number Tandem Repeat (VNTR), DNA Hybridization and Random Amplified Polymorphic DNA (RAPD) ([@A20130R16]-[@A20130R21]). Although MLST and PFGE have more discriminatory power, they are expensive, especially in developing countries ([@A20130R22]). RAPD-PCR has the advantage of being fast, reproducible, simple, and low-cost, thus, it is an appropriate approach for primary screening of epidemic strains in large number of isolates ([@A20130R23], [@A20130R24]).

2. Objectives {#sec109539}
=============

To our knowledge, limited data are available about genetic diversity of *P. aeruginosa* recovered from different clinical specimens in Isfahan; the purpose of the current study was to determine the antibiotic susceptibility profiles and genetic relatedness in *P. aeruginosa* isolated from patients admitted to a referral hospital in Isfahan, Iran.

3. Materials and Methods {#sec109543}
========================

3.1. Pseudomonas aeruginosa Isolation and Identification {#sec109540}
--------------------------------------------------------

This study was conducted at a teaching referral hospital of Isfahan, Iran, from February 2013 to November 2013. During the mentioned period, a total of 150 non-duplicate samples (urine, sputum, wound, blood, and eye discharge) taken from hospitalized-patients admitted to different wards of hospital were analyzed. Primary identification of *P. aeruginosa* was done based on the standard conventional biochemical tests, including Gram staining, catalase, oxidase, oxidative-fermentative (OF) tests, pigment production and growth at 42°C. Then, primary identification was further confirmed with species-specific PCR using ITS (16s-23s rRNA internal transcribed spacer) --primer ([@A20130R25], [@A20130R26]). The study was approved by the Ethics Committee of Isfahan University of Medical Sciences (No. 392063).

3.2. Antibiotic Susceptibility Test {#sec109541}
-----------------------------------

Resistance to antibiotics was evaluated by Kirby-Bauer's disk diffusion method according to CLSI (Clinical Laboratory Standard Institute) recommendation ([@A20130R27]). The following disks (MAST, UK) were applied: ceftazidime (CAZ, 30 µg), imipenem (IMP, 10 µg), meropenem (MEM, 10 µg), ciprofloxacin (CIP, 5 µg), aztreonam (ATM, 30 µg), polymyxin B (PB, 300 units), and amikacin (AMK, 30 µg). *P. aeruginosa* standard strain (ATCC 27853) was used as the quality control.

3.3. Random Amplified Polymorphic DNA-Genotyping {#sec109542}
------------------------------------------------

Optimized RAPD reactions mixtures comprised 2.5 µL 10x PCR buffer, 2.5 mM MgCl~2~, 300 µM of dNTPs, 1.7 U *Taq* DNA polymerase ( CinnaGen, Iran), 3 µL genomic DNA (40 ng), and 10 pM of 272- AGCGGGCCAA primer ([@A20130R21]) (Metabion, Germany) in 25 µL final volume. DNA amplification was carried out using Biometra thermocycler (Germany) and following a two-step program, 1) denaturation 5 min at 95°C, annealing 5 min at 36°C, elongation 5 min at 72°C, for 4 cycles, and 2) 31 cycles consisted of 94°C for 1 min, 45°C for 1 min, 72°C for 2 min, followed by a final extension at 72°C for 10 min ([@A20130R21]). Electrophoresis was carried out using 2% agarose gel (w/v) and 0.5x TBE (Tris-Boric acid-EDTA, pH = 7.5-8) buffer at 7 v/cm for 3h. We also used 100 bp DNA ladder (CinnaGen, Iran) as the standard molecular size (100 bp-3000 bp). Separated bands stained with ethidium bromide (0.5 µg/mL) and visualized picture was captured on Gel-documentation system (Uvitec, UK). RAPD-fingerprints were recorded as present (1) or absent (0) for each band. By means of FreeTree and TreeView softwares, Dice similarity coefficient and Unweighted Average Pair Group method (UPGMA) were used for similarity matrix calculation and cluster analysis, respectively ([@A20130R28], [@A20130R29]). Only major reproducible bands regardless of their intensity were considered for similarity matrix calculation ([@A20130R30]). We used cut-off value of ≥ 80% for determination of potential clonal relatedness ([@A20130R31]-[@A20130R33]).

4. Results {#sec109544}
==========

Out of 150 samples, 54 (36%) were positive for *P. aeruginosa* culture. Only one isolate per patient was recruited for study. Distribution of the 54 isolates were as follow, urine 39 (72.2 %), sputum 7 (13%), wound 5 (9.3%), blood 2 (3.7%), and eye discharge 1 (1.9%). The most frequent involved wards were ICU 28 (51.9%), followed by Graft 12 (22.2%), internal 5 (9.3%) and Surgery 9 (16.7%). Thirty-six isolates (66.7%) belonged to male patients and 18 (33.3%) belonged to female patients. The highest percentage (55.6%) of resistance was observed against ceftazidime and imipenem with 30 of the isolates being resistant; all isolates were sensitive to polymyxin B ([Figure 1](#fig20850){ref-type="fig"}). Twenty-eight (51.8%) isolates tested in the study revealed resistance to all applied antibiotics except for polymyxin B.

Electrophoresis patterns of RAPD-PCR for some isolates of studied *P. aeruginosa* are shown in [Figure 2](#fig20851){ref-type="fig"}. Genetic relatedness of clinical isolates of the detected *P. aeruginosa* has been carried out using RAPD-PCR assay, which showed 55% to 100% similarity ([Figure 3](#fig20852){ref-type="fig"}). The number of bands in RAPD typing varied from 2 to 12, with the length of 150 bp to 4300 bp. RAPD fingerprinting results of *P. aeruginosa* based on ≥ 80% showed 39 different groups ([Figure 3](#fig20852){ref-type="fig"}). Although the majority of isolates had unique fingerprint, group one composed of 3 isolates (patients S48, S29, S31). These urine-derived isolates were from different wards. Isolate S29 was fully sensitive to applied antibiotics, whereas isolates S31 and S48 were resistance to applied antibiotics ([Figure 3](#fig20852){ref-type="fig"}). Groups 22, 31, 35, and 36, each consisted of two isolates, were also obtained from the same ward ([Figure 3](#fig20852){ref-type="fig"}). Different antibiotic resistance patterns were observed among the members of the same cluster. Based on 65% similarity level, eight main cluster , with most of the strains belonging to cluster 1 were detected ([Figure 3](#fig20852){ref-type="fig"}).

![Antibiotic Resistance Percentage of *P. aeruginosa* Isolated From Patients Admitted to Studied Hospital](jjm-08-08-20130-i001){#fig20850}

![Electrophoresis Image of RAPD Genotyping\
Line 1, 14 DNA ladder (3000-100 bp), lines 2-13 showed 12 different RAPD types.](jjm-08-08-20130-g001){#fig20851}

![Dendogram Showing Genetic Diversity Among 54 Non-duplicate Clinical Isolates of *P. aeruginosa*\
Abbreviations: AMK, amikacin; AZT, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; IMP, imipenem; MP, meropenem; Sp, sputum; UC, urine; Wo, wound.](jjm-08-08-20130-i002){#fig20852}

5. Discussion {#sec109545}
=============

Constant monitoring of antibiotic susceptibility profiles and genetic relatedness among bacterial infectious agents are essential steps for infection control ([@A20130R34]). To improve our understanding about *P. aeruginosa* antibiotic resistance and their distribution, 54 non-duplicate isolates of *P. aeruginosa* by using Kirby-Bauer's disk diffusion and RAPD-PCR methods were investigated. *P. aeruginosa* involved in this study were highly resistant to different antibiotic families like, monobactams, cephalosporins, quinolones, and carbapenems ([Figure 1](#fig20850){ref-type="fig"}). Our isolates had the highest resistance rate to imipenem and meropenem (55.6%), which is higher than similar reports from Iran ([@A20130R11]-[@A20130R13]). In addition, increased percentage of resistance to ciprofloxacin and amikacin (53.7% and 48.1%, respectively) were observed in comparison with previous study (29% and 17%) that have been performed in the same hospital ([@A20130R35]). Although, in our investigated hospital, carbapenems (imipenem, meropenem) along with amikacin are the most currently used antibiotics for the treatment of *P. aeruginosa* infections, results of this study revealed that prescription of them should be limited.

In order to optimize treatment of *P. aeruginosa* infections in our hospital (also it can be mentioned as a limitation of this study), determination of resistance to other antibiotics like piperacillin, piperacillin-clavulanic acid, ticarcillin, ticarcillin-clavulanic acid, gentamicin, and cefepime, are essential to be evaluated in future studies. The finding of present study corresponds with the data presented by Haeili and associates, which showed the lowest percentage of resistance (0%) to polymyxin B ([@A20130R11]).

There are reports that PFGE and MLST are more reliable methods for establishing clonal relatedness among *P. aeruginosa* strains, but because of the high cost, their utilization is limited, especially in developing countries ([@A20130R36], [@A20130R37]). Allegedly, RAPD typing is a valuable and useful method for the evaluation of genetic diversity among *P. aeruginosa* isolates ([@A20130R21], [@A20130R23], [@A20130R24]). Out of various primers applied for RAPD-PCR, primer 272 was reliable because of its higher discriminatory power and reproducible profiles ([@A20130R38], [@A20130R39]). In the present study, all 54 isolates were typeable by RAPD-PCR; moreover, RAPD typing allowed us to reveal 54 unique finger prints among 54 clinical isolates of *P. aeruginosa*. Based on Dice similarity coefficient of greater than 80%, 39 groups were identified. Previous studies performed in Iran showed different distribution of genotypes. For instance, in the study of Salimi et al., by using RAPD typing, only 8 different groups among 129 isolates of *P. aeruginosa* were reported ([@A20130R40]). In addition, in another study conducted by Nanvazadeh et al. 9 groups among 50 clinical samples of *P. aeruginosa* were observed ([@A20130R41]). Using limited source for recovering *P. aeruginosa* may have limited the conclusions of these studies. General hygiene quality may also attribute to this genetic diversity. Although in a previous study the correlation between RAPD type and *P. aeruginosa* infection was suggested, our finding is not in agreement with these data ([@A20130R42]).

Based on the level of 65% similarity, eight major clusters were observed. Isolates with shared antibiotic resistance profiles were placed in the separate groups. Furthermore, our data demonstrated a weak correlation between RAPD and antibiotic resistance profiles; it is supported by the results of other studies ([@A20130R34], [@A20130R43]). In a number of cases, isolates belonged to same cluster showed different antibiotic resistance patterns. The reason for this diversity may be attributed to the involved different antibiotic resistance mechanisms ([@A20130R5]-[@A20130R7]). Moreover; results of the independent studies showed that determination of antibiotic resistance pattern as phenotypic method for *P. aeruginosa* typing has low discriminatory power ([@A20130R34], [@A20130R43]). According to our data, the majority of isolates probably originated from host itself, but cross infection of *P. aeruginosa* is possible to occur in studied hospital. For instance, isolates S48, S29, and S31 were recovered from urine of the patients in different wards or isolates 26 and 33 from the same ward and sample had genetic similarity (based on RAPD fingerprinting results). Before taking any decision, we think that clonal relatedness of obtained isolates should be confirmed by more discriminatory methods, such as PFGE or MLST.

In conclusion, prescription of common antibiotics (imipenem and amikacin) in our hospital due to high resistance rate must be restricted. According to our data, considerable genetic diversity exists among isolated *P. aeruginosa*; it is possible that different sources of *P. aeruginosa* be involved in our hospital that can lead to host colonization. In order to accurately control the infection, other *P. aeruginosa* isolated from hospital environment must be subjected to fingerprinting. Our results did not reveal epidemic clone of *P. aeruginosa*.

The authors would like to thank Mr Shokri and Mrs Beigi for their excellent assistance.

**Authors' Contributions:**Study design and data interpretation were performed by Hamid Vaez, Hajieh Ghasemian Safaei, Jamshid Faghri, Bahram Nasr Esfahani and Sharareh Moghim. Data collection and laboratory procedure were performed by Hamid Vaez, Hossein Fazeli, and Mansour Sedighi.

**Funding/Support:**This research was supported by Isfahan University of Medical Sciences (Grant No. 392063).
